The Learning Portal will be under maintenance Monday, 6 December between 6 AM and 5 PM EST. Portal functionality will be unavailable during this window.
We apologize for any inconvenience caused during this time.

  • Regulatory NewsRegulatory News

    After FDA's Top Cop Leaves, Agency Looks for Replacement

    The US Food and Drug Administration (FDA) is looking for a new director for its Office of Criminal Investigations (OCI), it announced on Thursday. The OCI is FDA’s criminal enforcement wing, charged with going after suspected violators of the  Federal Food, Drug and Cosmetic Act . The 29 May 2014 announcement on the government's federal jobs board, USAJobs.gov, explains that the agency is looking for someone who can develop and direct its criminal investigation activi...
  • America's (Other) Most Wanted: FDA Takes Aim at Drug and Device Fugitives

    The US Food and Drug Administration (FDA) is taking a page from the Federal Bureau of Investigation (FBI) in the hopes of tracking down some of the most egregious violators of federal food and drug law. On 15 April 2014, FDA's Office of Criminal Investigations (OCI), FDA's criminal enforcement division, launched a "Most Wanted Fugitives" page complete with 11 profiles of fugitives purported to be behind some of the worst violations of the Federal Food, Drug and Cosmetic...
  • FDA Raids Compounding Facility Linked to Meningitis Outbreak

    Criminal investigators from the US Food and Drug Administration (FDA) have raided the New England Compounding Center (NECC), the facility linked with supplying tainted injectable steroid products that have infected hundreds with a dangerous form of fungal meningitis that has already claimed the lives of 19. The move, made 17 October, is perhaps FDA's most forceful yet against the pharmacy. NECC has thus far been cooperating with the agency on an extensive but voluntary b...
  • As Death Penalty Opponents Target Drug Supply Regulations, States Move to New Methods

    • 11 July 2012
    US states are facing the prospect of losing further access to the execution drug propofol after the UK's business secretary announced his intent to publish new export controls aimed at banning the export of the drug from the country. The Guardian reports Business Secretary Vince Cable is set to publish the details of the proposal on Wednesday, 11 June 2012. "We are clear that the state should never be complicit in judiciary executions through the use of British drugs i...
  • States to FDA: Appeal Enforcement Discretion Decision

    A group of 15 states is calling on the US Department of Justice (DOJ) and the US Food and Drug Administration (FDA) to appeal a Judge's decision in a lawsuit against both FDA and the states' ability to obtain a drug commonly used in the execution of convicted criminals. CNN reports the states, all of which use lethal injection as their preferred method of execution, are having trouble obtaining sodium thiopental-an anesthetic commonly used as part of a multi-drug execu...
  • Merck Settles Vioxx Criminal Charges With US for $322 Million

    US pharmaceutical manufacturer Merck & Co. has settled criminal charges over the company's marketing of its painkiller drug Vioxx, reports Bloomberg . Merck will pay a $321.6 million criminal fine after US District Judge Patti Saris approved the settlement. This fine is in addition to a $628.3 million in civil claims paid out in November 2011, reports The Philadelphia Inquirer . Merck was charged with promoting Vioxx, a rheumatoid arthritis drug, illegally despite...
  • Prescribing Brand-Name Medications Criminal Offense Under New Greek Law

    Greece is reportedly banning the prescription of anything other than generic-brand medications , reports The Economist Intelligence Unit . The law, passed along with a series of other austerity measures, aims to curb spending by the country's social insurance funds to $3.8B in 2012. Greece has already run up debts of more than €500M for its drug program alone. "The new law also makes it a criminal offence for doctors to prescribe drugs by brand rather than g...